361 Capital’s CME Group CME Stock Holding History

361 Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,619	Closed	-$786K	–	173
2017 Q1	$786K	Buy	+6,619	New	+$796K	0.17%	122

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

361 Capital's CME Position: Q2 2017 in Review

361 Capital sold out of CME Group (CME) in Q2 2017, closing a stake of 6,619 shares — an estimated $786K sold.

361 Capital first reported a position in CME in Q1 2017 and held it in 1 quarter. The position peaked at $786K in Q1 2017. 772 funds tracked by Wall St. Rank hold CME as of Q2 2017.

361 Capital reported no remaining CME Group position as of Q2 2017 after selling out during the quarter.
361 Capital sold 6,619 CME Group shares in Q2 2017, an estimated $786K.
361 Capital first reported a position in CME Group in Q1 2017 and held it in 1 quarter.
361 Capital's CME Group position peaked at $786K in Q1 2017.
772 funds tracked by Wall St. Rank held CME Group as of Q2 2017.

Based on 361 Capital's 13F filing for Q2 2017, filed 15 Aug 2017.